BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 102 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $129,000 | +7.5% | 38,200 | -7.1% | 0.00% | – |
Q4 2018 | $120,000 | -52.6% | 41,100 | 0.0% | 0.00% | – |
Q3 2018 | $253,000 | -7.7% | 41,100 | +10.8% | 0.00% | – |
Q2 2018 | $274,000 | +25.7% | 37,100 | +11.7% | 0.00% | – |
Q1 2018 | $218,000 | -21.9% | 33,200 | 0.0% | 0.00% | – |
Q4 2017 | $279,000 | -27.2% | 33,200 | 0.0% | 0.00% | – |
Q3 2017 | $383,000 | -1.3% | 33,200 | 0.0% | 0.00% | – |
Q2 2017 | $388,000 | +62.3% | 33,200 | +71.1% | 0.00% | – |
Q1 2017 | $239,000 | -9.5% | 19,400 | 0.0% | 0.00% | – |
Q4 2016 | $264,000 | -31.6% | 19,400 | 0.0% | 0.00% | – |
Q3 2016 | $386,000 | +53.8% | 19,400 | 0.0% | 0.00% | – |
Q2 2016 | $251,000 | +71.9% | 19,400 | +24.4% | 0.00% | – |
Q1 2016 | $146,000 | -63.2% | 15,600 | -20.4% | 0.00% | – |
Q4 2015 | $397,000 | +65.4% | 19,600 | +18.8% | 0.00% | – |
Q3 2015 | $240,000 | -17.0% | 16,500 | +21.3% | 0.00% | – |
Q2 2015 | $289,000 | – | 13,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|